NCT05526534View on ClinicalTrials.gov

A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Gynecologic SurgeryHigh-flow Nasal CannulaPost-operative Pulmonary Complications
Interventions
DEVICE

heated humidified high flow nasal cannula oxygen therapy, HFNC

HFNC can accurately provide 21% \~ 100% oxygen concentration through air oxygen mixer. And through the heating and humidification device to provide 37℃, relative humidity of 100% gas, the maximum flow of 70L/min.

DEVICE

Nasal cannula oxygen

Nasal cannula oxygen has become a routine part of postoperative treatment

Trial Locations (1)

610000

RECRUITING

Sichuan Cancer Hospital and Research Institute, Chengdu

All Listed Sponsors
lead

Sichuan Cancer Hospital and Research Institute

OTHER